The Biden Administration has announced the launch of the first federally-supported “test-to-treat” sites for COVID that will allow for the rapid deployment of the antiviral pill Paxlovid.
The White House announced Thursday that it is launching the new sites in five states, with Rhode Island the first in line to get them and Minnesota the second, followed by New York, Illinois, and Massachusetts.
There are currently more than 2,500 “test-to-treat” sites across the country, mostly in pharmacies and community clinics. More than 60 of these are in Minnesota.
But these will be the first sites funded and supported by the federal government, with the Biden Administration saying it will send clinical personnel to Minnesota to “support staffing across several of Minnesota’s state-run testing sites.”